Skip to main content
Top
Published in: BMC Endocrine Disorders 1/2021

Open Access 01-12-2021 | Sickle Cell Anemia | Research article

Effect of combined G6PD deficiency and diabetes on protein oxidation and lipid peroxidation

Authors: Naif S. Karadsheh, Nisreen A. Quttaineh, Salem N. Karadsheh, Mohammad El-Khateeb

Published in: BMC Endocrine Disorders | Issue 1/2021

Login to get access

Abstract

Background

Oxidative Stress, an imbalance in the pro-oxidant/antioxidant homeostasis, occurs in many physiological and non-physiological processes and several human diseases, including diabetes mellitus (DM) and glucose-6-phosphate dehydrogenase (G6PD) deficiency. Since the incidence of G6PD deficiency in Jordan and many parts of the world is high, this study aimed to measure the effect of G6PD deficiency on the oxidative markers and the antioxidant glutathione (GSH) in diabetic and non-diabetic individuals.

Methods

Whole blood G6PD deficiency was screened by the fluorescent spot method, and erythrocyte G6PD activity was determined using a quantitative assay. Since protein carbonyl (PC) and malondialdehyde (MDA) are the most widely measured markers for protein and lipid oxidation, respectively, plasma PC and MDA, in addition to blood GSH were determined by spectrophotometric assays, as biomarkers of oxidative stress.

Results

The incidence of G6PD deficiency among the diabetic subjects was 15%. PC level in patients with diabetes and in G6PD-deficient subjects was 5.5 to 6-fold higher than in non-diabetic subjects with sufficient G6PD levels (p<0.001). This fold increase was doubled in diabetic patients with G6PD deficiency (p<0.001). Furthermore, the MDA level was significantly increased by 28-41% in G6PD-deficient, diabetics with sufficient G6PD, and diabetics with G6PD deficiency compared to MDA level in non-diabetic with sufficient G6PD. On the other hand, GSH was significantly reduced to half in G6PD-deficient subjects and in diabetics with G6PD-deficiency.

Conclusions

The results showed that diabetes and G6PD deficiency increased protein oxidation and lipid peroxidation. However, the combination of both disorders has an additive effect only on protein oxidation. On the other hand, GSH level is only reduced in G6PD deficiency. In addition, diabetes and G6PD deficiency appear to be genetically linked since the incidence of G6PD deficiency among people with diabetes is more than the general population.
Appendix
Available only for authorised users
Literature
1.
go back to reference Nkhoma ET, Poole C, Vannappagari V, Hall SA, Beutler E. The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta- analysis. Blood Cells Mol Dis. 2009;42:267–78.CrossRef Nkhoma ET, Poole C, Vannappagari V, Hall SA, Beutler E. The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta- analysis. Blood Cells Mol Dis. 2009;42:267–78.CrossRef
2.
go back to reference Luzzatto L. Glucose 6-phosphate dehydrogenase deficiency: from genotype to phenotype. Haematologica. 2006;91:1303–6.PubMed Luzzatto L. Glucose 6-phosphate dehydrogenase deficiency: from genotype to phenotype. Haematologica. 2006;91:1303–6.PubMed
3.
go back to reference Donnely R, Emslie-Smith AM, Gardner ID, Morris AD. ABC of arterial and venous disease: vascular complications of diabetes (Review). BMJ. 2000;320:1062–66.CrossRef Donnely R, Emslie-Smith AM, Gardner ID, Morris AD. ABC of arterial and venous disease: vascular complications of diabetes (Review). BMJ. 2000;320:1062–66.CrossRef
4.
go back to reference Fiorentino TV, Prioletta A, Zuo P, Foll F. Hyperglycemia-induced oxidative stress and its role in diabetes mellitus related cardiovascular disease. Curr Pharm Des. 2013; 19(32):5695–703.CrossRef Fiorentino TV, Prioletta A, Zuo P, Foll F. Hyperglycemia-induced oxidative stress and its role in diabetes mellitus related cardiovascular disease. Curr Pharm Des. 2013; 19(32):5695–703.CrossRef
5.
go back to reference Culler RG. Human Longevity and Aging: Possible role of reactive oxygen species. Ann NY Acad. Sci. 1991;621:1–28.CrossRef Culler RG. Human Longevity and Aging: Possible role of reactive oxygen species. Ann NY Acad. Sci. 1991;621:1–28.CrossRef
7.
go back to reference Bray TM. Antioxidants and oxidative stress in health and disease: Introduction. Proc Soc Exp Biol Med. 1999;222(3):195. Bray TM. Antioxidants and oxidative stress in health and disease: Introduction. Proc Soc Exp Biol Med. 1999;222(3):195.
8.
go back to reference Dalle-Donne I, Rossi R, Giustarini D, Milzani A, Colombo R. Protein carbonyl groups as biomarkers of oxidative stress. Clinica Chemica Acta. 2003;329:23–8.CrossRef Dalle-Donne I, Rossi R, Giustarini D, Milzani A, Colombo R. Protein carbonyl groups as biomarkers of oxidative stress. Clinica Chemica Acta. 2003;329:23–8.CrossRef
9.
go back to reference Niki E, Yoshida Y, Saito Y, Noguchi N. Lipid peroxidation: Mechanisms, inhibition,and biological effects. Biochemical and Biophysical Research Communications. 2005;338:668–76.CrossRef Niki E, Yoshida Y, Saito Y, Noguchi N. Lipid peroxidation: Mechanisms, inhibition,and biological effects. Biochemical and Biophysical Research Communications. 2005;338:668–76.CrossRef
10.
go back to reference Fibach E, Rachmilewitz E. The role of oxidative stress in hemolytic anemia. Curr Mol Med. 2008; 8(7):609–19.CrossRef Fibach E, Rachmilewitz E. The role of oxidative stress in hemolytic anemia. Curr Mol Med. 2008; 8(7):609–19.CrossRef
11.
go back to reference Karadsheh NS, Moses L, Ismail SI, Devaney JM, Hoffman E. Molecular heterogeneity of glucose-6-phosphate dehydrogenase deficiency in Jordan. Haematologica, 2005; 90(12):1693–4.PubMed Karadsheh NS, Moses L, Ismail SI, Devaney JM, Hoffman E. Molecular heterogeneity of glucose-6-phosphate dehydrogenase deficiency in Jordan. Haematologica, 2005; 90(12):1693–4.PubMed
12.
go back to reference Karadsheh NS, Awidi AS, Tarawneh MC. Two new gucose-6 phosphate dehydrogenase (G6PD) variants associated with hemolytic anemia: G6PD Amman-1 and G6PD Amman-2. Am. J. Hematol. 1986;22:185–92. Karadsheh NS, Awidi AS, Tarawneh MC. Two new gucose-6 phosphate dehydrogenase (G6PD) variants associated with hemolytic anemia: G6PD Amman-1 and G6PD Amman-2. Am. J. Hematol. 1986;22:185–92.
13.
go back to reference Ajlouni K, Khader YS, Batieha A, Ajlouni H, El-Khateeb M. An increase in prevalence of diabetes mellitus in Jordan over 10 years. J Diabetes Complicat. 2008; 22: 317–24.CrossRef Ajlouni K, Khader YS, Batieha A, Ajlouni H, El-Khateeb M. An increase in prevalence of diabetes mellitus in Jordan over 10 years. J Diabetes Complicat. 2008; 22: 317–24.CrossRef
14.
go back to reference Niazi GA. Glucose-6-phosphate dehydrogenase deficiency and diabetes mellitus. Int J Hematol. 1991;54(4):295-8. Niazi GA. Glucose-6-phosphate dehydrogenase deficiency and diabetes mellitus. Int J Hematol. 1991;54(4):295-8.
15.
go back to reference Santana MS, Monteiro WM, Costa MRF, et al. High frequency of Diabetes and impaired fasting glucose in patients with glucose-6-phosphate dehydrogenase deficiency in the Western Brazilian Amazon. Am J Trop Med Hyg. 2014;91(1):74–6.CrossRef Santana MS, Monteiro WM, Costa MRF, et al. High frequency of Diabetes and impaired fasting glucose in patients with glucose-6-phosphate dehydrogenase deficiency in the Western Brazilian Amazon. Am J Trop Med Hyg. 2014;91(1):74–6.CrossRef
16.
go back to reference Menounos P, Zervas C, Garinis G, Doukas C, Kolokithopoulos D, Tegos C, Patrinos GP. Molecular heterogeneity of the glucose-6-phosphate dehydrogenase deficiency in the Hellenic population. Hum Hered. 2000;50(4):237-41. https://doi.org/10.1159/000022922. Erratum in: Hum Hered 2000;50(6):369. Menounos P, Zervas C, Garinis G, Doukas C, Kolokithopoulos D, Tegos C, Patrinos GP. Molecular heterogeneity of the glucose-6-phosphate dehydrogenase deficiency in the Hellenic population. Hum Hered. 2000;50(4):237-41. https://​doi.​org/​10.​1159/​000022922. Erratum in: Hum Hered 2000;50(6):369.
17.
go back to reference Nwanjo HU, Oze G, Okafor MC, Nwosu D, Nwankpa P. Protective role of Phyllantus niruri extract on serum lipid profiles and oxidative stress in hepatocytes of diabetic rats. Afr J Biotech. 2007;6:1744–49.CrossRef Nwanjo HU, Oze G, Okafor MC, Nwosu D, Nwankpa P. Protective role of Phyllantus niruri extract on serum lipid profiles and oxidative stress in hepatocytes of diabetic rats. Afr J Biotech. 2007;6:1744–49.CrossRef
18.
go back to reference Hernández-Marco R, Codoñer-Franch P, Morales S, Villaescusa CD, García LB, Bellés BG. Oxidant/antioxidant status and hyperfiltration in young patients with type 1 diabetes mellitus. Pediatr Nephrol. 2009;24:121–27.CrossRef Hernández-Marco R, Codoñer-Franch P, Morales S, Villaescusa CD, García LB, Bellés BG. Oxidant/antioxidant status and hyperfiltration in young patients with type 1 diabetes mellitus. Pediatr Nephrol. 2009;24:121–27.CrossRef
19.
go back to reference Lai YK, Lai NM, Lee SW. Glucose-6-phosphate dehydrogenase deficiency and risk of diabetes: a systematic review and meta-analysis. Ann Hematol. 2017;96(5):839–45.CrossRef Lai YK, Lai NM, Lee SW. Glucose-6-phosphate dehydrogenase deficiency and risk of diabetes: a systematic review and meta-analysis. Ann Hematol. 2017;96(5):839–45.CrossRef
20.
go back to reference Pinna P, Contini EL, Carru C, Solinas G. Glucose-6-phosphate dehydrogenase deficiency and diabetes mellitus with severe retinal complications in a Sardinian population, Italy. Int J Med Sci. 2013;10:1907–13. Pinna P, Contini EL, Carru C, Solinas G. Glucose-6-phosphate dehydrogenase deficiency and diabetes mellitus with severe retinal complications in a Sardinian population, Italy. Int J Med Sci. 2013;10:1907–13.
21.
go back to reference Antwi-Baffour S, Adjei JK, Forson PO, Akakpo S, Kyeremeh R, Seidu MA. Comorbidity of glucose-6-Phosphate dehydrogenase deficiency and sickle cell disease exert significant effect on RBC indices. Anemia. 2019;2019:3179173. Antwi-Baffour S, Adjei JK, Forson PO, Akakpo S, Kyeremeh R, Seidu MA. Comorbidity of glucose-6-Phosphate dehydrogenase deficiency and sickle cell disease exert significant effect on RBC indices. Anemia. 2019;2019:3179173.
22.
go back to reference Fasola FA, Fowodu FO, Shokunbi WA, Kotila TR. The effect of the coinheritance of glucose-6-phosphate dehydrogenase deficiency on the severity of sickle cell disease. Niger Postgrad Med. 2019;26(2):118–22.CrossRef Fasola FA, Fowodu FO, Shokunbi WA, Kotila TR. The effect of the coinheritance of glucose-6-phosphate dehydrogenase deficiency on the severity of sickle cell disease. Niger Postgrad Med. 2019;26(2):118–22.CrossRef
23.
go back to reference Vinzio S, Andres E, Perrin AE, Schlienger JL, Gaichot B. Glibenclamide-induced acute haemolytic anaemia revealing a G6PD-deficiency. Diabetes Res Clin Pract. 2004;64:181–3.CrossRef Vinzio S, Andres E, Perrin AE, Schlienger JL, Gaichot B. Glibenclamide-induced acute haemolytic anaemia revealing a G6PD-deficiency. Diabetes Res Clin Pract. 2004;64:181–3.CrossRef
Metadata
Title
Effect of combined G6PD deficiency and diabetes on protein oxidation and lipid peroxidation
Authors
Naif S. Karadsheh
Nisreen A. Quttaineh
Salem N. Karadsheh
Mohammad El-Khateeb
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2021
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-021-00911-6

Other articles of this Issue 1/2021

BMC Endocrine Disorders 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.